GHCM
BDSI

Glen Harbor Capital Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Glen Harbor Capital Management’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-24,668
Closed -$43K – 1311
2016
Q4 		$43K Buy
+24,668
New +$50.4K ﹤0.01% 1115

Other funds holding BDSI

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Glen Harbor Capital Management's BDSI Position: Q1 2017 in Review

Glen Harbor Capital Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2017, closing a stake of 24,668 shares — an estimated $43K sold.

Glen Harbor Capital Management first reported a position in BDSI in Q4 2016 and held it in 1 quarter. The position peaked at $43K in Q4 2016. 63 funds tracked by Wall St. Rank hold BDSI as of Q1 2017.

  • Glen Harbor Capital Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2017 after selling out during the quarter.
  • Glen Harbor Capital Management sold 24,668 BioDelivery Sciences International, Inc. shares in Q1 2017, an estimated $43K.
  • Glen Harbor Capital Management first reported a position in BioDelivery Sciences International, Inc. in Q4 2016 and held it in 1 quarter.
  • Glen Harbor Capital Management's BioDelivery Sciences International, Inc. position peaked at $43K in Q4 2016.
  • 63 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2017.

Based on Glen Harbor Capital Management's 13F filing for Q1 2017, filed 25 Apr 2017.